Around 1 in 5 people diagnosed with cancer in the UK take part in a clinical trial.
A trial looking at treatment for children with anaplastic large cell lymphoma (ALCL-Relapse, NHL 2006 01)
Cancer type:
Blood cancers
Children's cancers
High grade lymphoma
Lymphoma
Non-Hodgkin lymphoma
Status:
Results
Phase:
Phase 3
This trial looked at chemotherapy for children with a type of non Hodgkin lymphoma called anaplastic large cell lymphoma (ALCL) that had not responded to treatment or had come back after treatment. The trial was for children and young people up to the age of 22.
ALCL is a rare type of high grade non Hodgkin lymphoma. Children and young people with ALCL usually have treatment with a combination of different chemotherapy drugs. But for a very small number of children, the treatment does not work or their ALCL comes back later (
).
The aims of this study were to
- See if chemotherapy and a stem cell transplant improved the outcome for children and young people who had relapsed ALCL
- Find out the effect of a drug called vinblastine in children and young people who hadn’t had this drug as part of their initial treatment
Summary of results
This trial closed in the UK as very few patients were recruited.
Recruitment start:
Recruitment end:
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.
Chief Investigator
Dr Denise Williams
Supported by
Children's Cancer and Leukaemia Group (CCLG)
National Institute for Health Research Cancer Research Network (NCRN)
If you have questions about the trial please contact our cancer information nurses
Freephone 0808 800 4040
Last review date
CRUK internal database number:
Oracle 764
Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.
Around 1 in 5 people take part in clinical trials
